United States v. Arthrex, Inc.
Headline: Patent judges’ independence limited as Court rules the patent office Director may review final PTAB decisions, restoring presidential accountability and prompting agency re-evaluation of patents nationwide.
Holding: The Court held that Administrative Patent Judges’ unreviewable authority conflicts with the Appointments Clause and that the patent office Director may review and issue final PTAB decisions, with the case remanded for rehearing consideration.
- Gives the patent office Director authority to review PTAB final decisions.
- May change outcomes of ongoing patent challenges through Director rehearings.
- Patent owners and challengers face renewed political accountability and possible shifts in patent-review strategy.
Summary
Background
A medical-device company owned a patent that other device makers challenged before the Patent Trial and Appeal Board (a panel made up largely of Administrative Patent Judges, or APJs). A three-judge PTAB panel found the patent invalid. On appeal, the Federal Circuit held that APJs were principal officers and struck down their protections from removal, which triggered review by the Supreme Court.
Reasoning
The core question was whether APJs’ power to issue final decisions for the Executive Branch fits with the Constitution’s rule about how officers must be appointed. The Court applied an earlier test saying inferior officers must be directed and supervised by officers appointed by the President with Senate approval. Because PTAB decisions were final inside the agency and only the PTAB itself could rehear them, the APJs exercised unreviewable executive authority incompatible with their method of appointment. To fix that problem without invalidating the whole review system, the Court held the Director of the Patent and Trademark Office may review final PTAB decisions and issue decisions for the Board.
Real world impact
The Court vacated the Federal Circuit’s remedy and sent the cases back to the agency so the Acting Director can decide whether to rehear the patent challenge. This change gives a politically accountable official the discretion to review and potentially overturn PTAB rulings. The opinion does not resolve the patent dispute on the merits and future outcomes can still change on rehearing or appeal.
Dissents or concurrances
The decision drew several separate opinions: a majority opinion (Parts I–II and remedial Part III by the Chief Justice), a partial concurrence and partial dissent, and separate dissents. Justices disagreed about whether the proper fix was to remove APJs’ protections, to leave them alone, or to take other remedies.
Ask about this case
Ask questions about the entire case, including all opinions (majority, concurrences, dissents).
What was the Court's main decision and reasoning?
How did the dissenting opinions differ from the majority?
What are the practical implications of this ruling?